2027 SPEAKERS

Eunice Alvazzi, Global Head, Hematology, Nephrology, Transplant & Neurology, Access & Pricing, Alexion – AstraZeneca Rare Disease

Eunice Alvazzi | Global Head, Hematology, Nephrology, Transplant & Neurology, Access & Pricing | Alexion – AstraZeneca Rare Disease » speaking at World EPA Congress

Michael Andreou, Value & Access, Biogen

Michael Andreou | Value & Access | Biogen » speaking at World EPA Congress

Marta Andreykiv, VP, Viatris

Marta Andreykiv | VP | Viatris » speaking at World EPA Congress

Ad Antonisse, Director, Market Access & Corporate Affairs, AstraZeneca

Ad Antonisse | Director, Market Access & Corporate Affairs | AstraZeneca » speaking at World EPA Congress

Jorge Arellano, Senior Vice President, Global Head PAVE, Pricing, Access, Value & Evidence, BioMarin

Jorge Arellano | Senior Vice President, Global Head PAVE, Pricing, Access, Value & Evidence | BioMarin » speaking at World EPA Congress

Fabienne Bartoli, Inspector General, French National Authority for Health

Fabienne Bartoli | Inspector General | French National Authority for Health » speaking at World EPA Congress

Alex Bastian, Vice President, Commercial Strategy, Memo Therapeutics

Alex Bastian | Vice President, Commercial Strategy | Memo Therapeutics » speaking at World EPA Congress

Stefano Benvenuti, Head of Public Affairs and Market Access, Fondazione Telethon

Stefano Benvenuti | Head of Public Affairs and Market Access | Fondazione Telethon » speaking at World EPA Congress

Tomer Benzaken, Director, Head of Commercial Operations & Trade, Astellas

Tomer Benzaken | Director, Head of Commercial Operations & Trade | Astellas » speaking at World EPA Congress

Katja Berg, Global Director, Innovative Value and Access Strategy, Global Market Access and Pricing, BBU, AstraZeneca

Katja Berg | Global Director, Innovative Value and Access Strategy, Global Market Access and Pricing, BBU | AstraZeneca » speaking at World EPA Congress

Ingrid Bettum, Senior Adviser, Unit for HTA Cancer Medicines, Norwegian Medicines Agency

Ingrid Bettum | Senior Adviser, Unit for HTA Cancer Medicines | Norwegian Medicines Agency » speaking at World EPA Congress

Thomas Bols, Head of Government Affairs and Patient Advocacy, EMEA & APAC, PTC Therapeutics

Thomas Bols | Head of Government Affairs and Patient Advocacy, EMEA & APAC | PTC Therapeutics » speaking at World EPA Congress

Pedro Borga, Regional Market Access and Pricing Director, Amicus Therapeutics

Pedro Borga | Regional Market Access and Pricing Director | Amicus Therapeutics » speaking at World EPA Congress

Okke-Jaap Bosgra, Director International Market Access, Natera

Okke-Jaap Bosgra | Director International Market Access | Natera » speaking at World EPA Congress

Vidya Breeveld, founder & CEO, Transmineo

Vidya Breeveld | founder & CEO | Transmineo » speaking at World EPA Congress

Thomas Broekhoff, Program Manager Medicines, hollandbio

Thomas Broekhoff | Program Manager Medicines | hollandbio » speaking at World EPA Congress

Henriette Burghoorn, Associate Director, Market Access, Gilead Sciences

Henriette Burghoorn | Associate Director, Market Access | Gilead Sciences » speaking at World EPA Congress

Antonella Cardone, CEO, Cancer Patients Europe

Antonella Cardone | CEO | Cancer Patients Europe » speaking at World EPA Congress

Lamis Chahoud, Head of Access & Pricing Region New Markets, BeOne Medicines

Lamis Chahoud | Head of Access & Pricing Region New Markets | BeOne Medicines » speaking at World EPA Congress

Bruno Cherel, Senior Director, Head of Pricing, Jazz Pharmaceuticals

Bruno Cherel | Senior Director, Head of Pricing | Jazz Pharmaceuticals » speaking at World EPA Congress

Jag Chhatwal, Director, Center for Health Technology Assessment, Harvard Medical School

Jag Chhatwal | Director, Center for Health Technology Assessment | Harvard Medical School » speaking at World EPA Congress

Sally Chung, Vice President, Value & Access International Operations & Excellence, Ipsen

Sally Chung | Vice President, Value & Access International Operations & Excellence | Ipsen » speaking at World EPA Congress

Marie-Monique de Molliens, Global Market Access Horizon Scanning Senior Director, Sanofi

Marie-Monique de Molliens | Global Market Access Horizon Scanning Senior Director | Sanofi » speaking at World EPA Congress

Eva Susanne Dietrich, Professor, Departments for Clinical Pharmacy and Regulatory Affairs, University of Bonn

Eva Susanne Dietrich | Professor, Departments for Clinical Pharmacy and Regulatory Affairs | University of Bonn » speaking at World EPA Congress

Toon Digneffe, Head Public Affairs & Public Policy, Takeda

Toon Digneffe | Head Public Affairs & Public Policy | Takeda » speaking at World EPA Congress

Riad Dirani, Vice President, Global Health Economics, Value and Outcomes, Teva Pharmaceuticals

Riad Dirani | Vice President, Global Health Economics, Value and Outcomes | Teva Pharmaceuticals » speaking at World EPA Congress

Maurice Driessen, Senior Director, Head of Inline Brands, GHEVO, Teva Pharmaceuticals

Maurice Driessen | Senior Director, Head of Inline Brands, GHEVO | Teva Pharmaceuticals » speaking at World EPA Congress

Marcus Droege, Executive Vice President, Managing Director, Pharmaconcepts

Marcus Droege | Executive Vice President, Managing Director | Pharmaconcepts » speaking at World EPA Congress

Marieangela Economopoulou, Head of External Affairs and Patient Value Access - Greece, Cyprus, Malta, Takeda Hellas

Marieangela Economopoulou | Head of External Affairs and Patient Value Access - Greece, Cyprus, Malta | Takeda Hellas » speaking at World EPA Congress

Maria Eriksson, Medical Assessor, Ph D., TLV

Maria Eriksson | Medical Assessor, Ph D. | TLV » speaking at World EPA Congress

Stefaan Fiers, Chapter Head, External Affairs, Roche

Stefaan Fiers | Chapter Head, External Affairs | Roche » speaking at World EPA Congress

Steven Flostrand, Executive Director, Value, Access & Pricing, Incyte Corp.

Steven Flostrand | Executive Director, Value, Access & Pricing | Incyte Corp. » speaking at World EPA Congress

Katie Gardner, Global Head of Market Access Excellence & Capabilities, Astellas

Katie Gardner | Global Head of Market Access Excellence & Capabilities | Astellas » speaking at World EPA Congress

Ramiro Gilardino, Associate Professor of Public Health, Buenos Aires School of Public Health

Ramiro Gilardino | Associate Professor of Public Health | Buenos Aires School of Public Health » speaking at World EPA Congress

Brad Groves, Director, NICE Advice, National Institute for Health & Care Excellence (NICE)

Brad Groves | Director, NICE Advice | National Institute for Health & Care Excellence (NICE) » speaking at World EPA Congress

Thomas Grub, Director, Global Pricing and Market Access, Medac GmbH

Thomas Grub | Director, Global Pricing and Market Access | Medac GmbH » speaking at World EPA Congress

Neil Grubert, Global Market Access Expert, Independent

Neil Grubert | Global Market Access Expert | Independent » speaking at World EPA Congress

Marlene Gyldmark, EU HTA lead, BeOne Medicines

Marlene Gyldmark | EU HTA lead | BeOne Medicines » speaking at World EPA Congress

Patrick Hopkinson, Independent HTA Expert, Independent HTA Expert

Patrick Hopkinson | Independent HTA Expert | Independent HTA Expert » speaking at World EPA Congress

Amy Israel, Senior Advisor, Access to Medicines, Union for International Cancer Control

Amy Israel | Senior Advisor, Access to Medicines | Union for International Cancer Control » speaking at World EPA Congress

Dr Nicolas Jamet, Global Pricing and Market Access Lead, GSK

Dr Nicolas Jamet | Global Pricing and Market Access Lead | GSK » speaking at World EPA Congress

Sophie Janssens, Sr VP, Global Head of Patient Impact Maximization (GO), UCB

Sophie Janssens | Sr VP, Global Head of Patient Impact Maximization (GO) | UCB » speaking at World EPA Congress

Iroda Jurabekova, Executive Director, Global Market Access, Oncology, Boehringer Ingelheim

Iroda Jurabekova | Executive Director, Global Market Access, Oncology | Boehringer Ingelheim » speaking at World EPA Congress

Madhu Kabra, Global Director, HEOR, MKGlobal

Madhu Kabra | Global Director, HEOR | MKGlobal » speaking at World EPA Congress

Elizabeth Kinter, Vice President, Head of Global Market Access, Avidity BioSciences

Elizabeth Kinter | Vice President, Head of Global Market Access | Avidity BioSciences » speaking at World EPA Congress

Sven Klijn, Director, HEOR Evidence Acceleration & Innovation, Bristol Myers Squibb

Sven Klijn | Director, HEOR Evidence Acceleration & Innovation | Bristol Myers Squibb » speaking at World EPA Congress

Jolanda Koenders, Head lx, Takeda

Jolanda Koenders | Head lx | Takeda » speaking at World EPA Congress

Charles Makin, Head of US Real World Evidence & Epidemiology, Boehringer Ingelheim

Charles Makin | Head of US Real World Evidence & Epidemiology | Boehringer Ingelheim » speaking at World EPA Congress

Bill Malcolm, Executive Director, Global HEOR Economic & Predictive Modelling, Bristol Myers Squibb

Bill Malcolm | Executive Director, Global HEOR Economic & Predictive Modelling | Bristol Myers Squibb » speaking at World EPA Congress

Marco Marchetti, Co-Chair, HTA Coordination Group & Director, Health Technology Assessment Unit, European Commission & National Agency for Regional Care Services, Italy

Marco Marchetti | Co-Chair, HTA Coordination Group & Director, Health Technology Assessment Unit | European Commission & National Agency for Regional Care Services, Italy » speaking at World EPA Congress

Silvy Mardiguian, Head of HEOR, Europe & New Markets, BeOne Medicines

Silvy Mardiguian | Head of HEOR, Europe & New Markets | BeOne Medicines » speaking at World EPA Congress

Sandra Margunato Debay, Executive Director, Global Value, Access and Pricing, Revolution Medicines

Sandra Margunato Debay | Executive Director, Global Value, Access and Pricing | Revolution Medicines » speaking at World EPA Congress

Emanuele Marsili, Global Access Director, CSL

Emanuele Marsili | Global Access Director | CSL » speaking at World EPA Congress

Vanessa Mirsky, Vice President, Life Sciences Data Strategy, RWE/RWD, OneOncology

Vanessa Mirsky | Vice President, Life Sciences Data Strategy, RWE/RWD | OneOncology » speaking at World EPA Congress

Alessandro Monaco, General Manager, Oliba Healthcare and Pharma

Alessandro Monaco | General Manager | Oliba Healthcare and Pharma » speaking at World EPA Congress

Santiago Moreno, Global Head HEOR, Menarini

Santiago Moreno | Global Head HEOR | Menarini » speaking at World EPA Congress

Paolo Morgese, Vice President, Public Affairs, Europe, Alliance for Regenerative Medicine

Paolo Morgese | Vice President, Public Affairs, Europe | Alliance for Regenerative Medicine » speaking at World EPA Congress

Gorden Muduma, Senior Director Market Access -EMEA Region, Orchard Therapeutics

Gorden Muduma | Senior Director Market Access -EMEA Region | Orchard Therapeutics » speaking at World EPA Congress

Michael Mueller, Head of Market Access, Western Europe, Sun Pharma

Michael Mueller | Head of Market Access, Western Europe | Sun Pharma » speaking at World EPA Congress

Dr Thomas Müller, Head Of Directorate General 1 - Drugs, Medical Devices, Biotechnology, Federal Ministry of Health Germany

Dr Thomas Müller | Head Of Directorate General 1 - Drugs, Medical Devices, Biotechnology | Federal Ministry of Health Germany » speaking at World EPA Congress

Funmi Oluwa, Head of Market Access & External Engagement, UCB Pharma

Funmi Oluwa | Head of Market Access & External Engagement | UCB Pharma » speaking at World EPA Congress

Gianfranco Parlato, Global Head of Value Access, Pricing & Policy CMVD (CardioMetabolism & Venous Diseases), Servier International

Gianfranco Parlato | Global Head of Value Access, Pricing & Policy CMVD (CardioMetabolism & Venous Diseases) | Servier International » speaking at World EPA Congress

Adam PARNABY, Lead, Global Policy & Access, Bristol Myers Squibb

Adam PARNABY | Lead, Global Policy & Access | Bristol Myers Squibb » speaking at World EPA Congress

Peter Pemberton-Ross, Head, HE & HTA Strategy, Biogen

Peter Pemberton-Ross | Head, HE & HTA Strategy | Biogen » speaking at World EPA Congress

Trine Pilgaard, Director, Head of Market Access, Denmark and Iceland, Pfizer

Trine Pilgaard | Director, Head of Market Access, Denmark and Iceland | Pfizer » speaking at World EPA Congress

Uffe Ploug, Global Health Economics Director, UCB

Uffe Ploug | Global Health Economics Director | UCB » speaking at World EPA Congress

Annette Powers, Senior Vice President, Global Access & Value and Public Policy (GAVP), Astellas

Annette Powers | Senior Vice President, Global Access & Value and Public Policy (GAVP) | Astellas » speaking at World EPA Congress

Sonia Pulido Sánchez, Co-Chair of the Subgroup for Joint Scientific Consultations of the HTACG, AEMPS

Sonia Pulido Sánchez | Co-Chair of the Subgroup for Joint Scientific Consultations of the HTACG | AEMPS » speaking at World EPA Congress

Jennifer Quinn, Senior Director, Head of Market Access, Europe and International, Jazz Pharmaceuticals

Jennifer Quinn | Senior Director, Head of Market Access, Europe and International | Jazz Pharmaceuticals » speaking at World EPA Congress

Marco Rauland, Vice President, Market Access, Strategy, Pricing and Analytics, Merck KGaA

Marco Rauland | Vice President, Market Access, Strategy, Pricing and Analytics | Merck KGaA » speaking at World EPA Congress

Sandra Rose, Head of Market Access & Public Affairs, Chiesi

Sandra Rose | Head of Market Access & Public Affairs | Chiesi » speaking at World EPA Congress

Charlotte Roy, Life Sciences Policy and Influencing Manager, The Muscular Dystrophy U.K.

Charlotte Roy | Life Sciences Policy and Influencing Manager | The Muscular Dystrophy U.K. » speaking at World EPA Congress

Noem Sain, EU Market Access Lead, UCB Pharma

Noem Sain | EU Market Access Lead | UCB Pharma » speaking at World EPA Congress

Steve Sandor, Vice President, Market Access, Trade and Government Affairs, Paratek Pharmaceuticals , Inc.

Steve Sandor | Vice President, Market Access, Trade and Government Affairs | Paratek Pharmaceuticals , Inc. » speaking at World EPA Congress

Ayman Semaan, Head of Market Access & Pricing, Biologix

Ayman Semaan | Head of Market Access & Pricing | Biologix » speaking at World EPA Congress

Hans Severens, Independent HTA Expert, Severens HTA consultancy

Hans Severens | Independent HTA Expert | Severens HTA consultancy » speaking at World EPA Congress

Jiri Smejkal, Access & Value Head PDT, Takeda

Jiri Smejkal | Access & Value Head PDT | Takeda » speaking at World EPA Congress

Joshua Smeltzer, Head of Pricing & Contracting, Market Access Germany, Ipsen Pharma GmbH

Joshua Smeltzer | Head of Pricing & Contracting, Market Access Germany | Ipsen Pharma GmbH » speaking at World EPA Congress

Raphael Sonabend-Friend, Associate Director, National Institute for Health and Care Excellence

Raphael Sonabend-Friend | Associate Director | National Institute for Health and Care Excellence » speaking at World EPA Congress

Manoj Sood, Commercial Access Director, Independent Market Access Expert

Manoj Sood | Commercial Access Director | Independent Market Access Expert » speaking at World EPA Congress

Lotte Steuten, Deputy CEO, Office of Health Economics

Lotte Steuten | Deputy CEO | Office of Health Economics » speaking at World EPA Congress

Jan Swiderski, Head of Government Affairs & Policy, Kyowa Kirin International

Jan Swiderski | Head of Government Affairs & Policy | Kyowa Kirin International » speaking at World EPA Congress

Siguroli Teitsson, Director, GHEOR Economic & Predictive Modeling, Bristol Myers Squibb

Siguroli Teitsson | Director, GHEOR Economic & Predictive Modeling | Bristol Myers Squibb » speaking at World EPA Congress

Elena Tricca, Vice President, Global Market Access and Pricing, BioPharmaceuticals, AstraZeneca

Elena Tricca | Vice President, Global Market Access and Pricing, BioPharmaceuticals | AstraZeneca » speaking at World EPA Congress

Stine Trolle, Senior Advisor, Danish Medicines Agency (DKMA)

Stine Trolle | Senior Advisor | Danish Medicines Agency (DKMA) » speaking at World EPA Congress

Sheela Upadhyaya, Life Science Advisor in Rare Diseases, Openflex Ltd

Sheela Upadhyaya | Life Science Advisor in Rare Diseases | Openflex Ltd » speaking at World EPA Congress

Caroline van der Meijden, Director, iMTA

Caroline van der Meijden | Director | iMTA » speaking at World EPA Congress

Goedele Van Haasteren, Staff Member, Federal Office of Public Health, Switzerland

Goedele Van Haasteren | Staff Member | Federal Office of Public Health, Switzerland » speaking at World EPA Congress

Oliver van Zon, VP Market Access Europe, Crinetics Pharmaceuticals

Oliver van Zon | VP Market Access Europe | Crinetics Pharmaceuticals » speaking at World EPA Congress

Yvette Venable, Global Senior Director of Payer Partnerships and Policy, AstraZeneca

Yvette Venable | Global Senior Director of Payer Partnerships and Policy | AstraZeneca » speaking at World EPA Congress

Rosa Maria Vivanco Hidalgo, Head of Health Technology Assessment, AQuAS Gencat

Rosa Maria Vivanco Hidalgo | Head of Health Technology Assessment | AQuAS Gencat » speaking at World EPA Congress

Reg Waldeck, Vice President, Head Global Market Access, Bayer

Reg Waldeck | Vice President, Head Global Market Access | Bayer » speaking at World EPA Congress

Billy West, Equitable Access Lead, Wellcome Trust

Billy West | Equitable Access Lead | Wellcome Trust » speaking at World EPA Congress

Anne Willemsen, Co-chair JCA Subgroup, Zorginstituut Nederland

Anne Willemsen | Co-chair JCA Subgroup | Zorginstituut Nederland » speaking at World EPA Congress

Keir Woods, Vice President, Global Value Demonstration, Market Access & Pricing (GVAP), Oncology, Merck Group

Keir Woods | Vice President, Global Value Demonstration, Market Access & Pricing (GVAP), Oncology | Merck Group » speaking at World EPA Congress

Get Involved 
 

Sponsorship & Exhibition Sales


Oliver Hersey-Swan
oliver.hersey-swan@terrapinn.com

Speaking Opportunities


Isla Sutherland
isla.sutherland@terrapinn.com
 

Marketing Opportunities


Hidy Lee
hidy.lee@terrapinn.com